Ashwin Narain
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- Extracellular vesicles in disease
- Genomics and Chromatin Dynamics
Papers in
-
- Protein Degradation and Inhibitors 2
- RNA Research and Splicing 2
- RNA and protein synthesis mechanisms 2
- Ubiquitin and proteasome pathways 2
- Genomics and Chromatin Dynamics 2
- Oncology 1
- CAR-T cell therapy research 1
- Co-authors
- Simran Asawa (1 shared paper)Yogita Patil‐Sen (1 shared paper)Bikash Adhikari (3 shared papers)Elmar Wolf (4 shared papers)Pranjali Bhandare (3 shared papers)Andreas Schlösser (3 shared papers)Apoorva Baluapuri (2 shared papers)Christoph Sotriffer (1 shared paper)
- Journals
- Molecular Cell (1 paper)Nature Chemical Biology (1 paper)Nucleic Acids Research (1 paper)Nanomedicine (1 paper)STAR Protocols (1 paper)
- Partner nations
- GermanyIndiaUnited Kingdom
In The Last Decade
Ashwin Narain
5 papers receiving 332 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 79
- Molecular Biology 223
- Biomedical Engineering 103
- Oncology 55
- Pharmaceutical Science 12
Countries citing papers authored by Ashwin Narain
This map shows the geographic impact of Ashwin Narain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Narain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Narain more than expected).
Fields of papers citing papers by Ashwin Narain
This network shows the impact of papers produced by Ashwin Narain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Narain. The network helps show where Ashwin Narain may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin Narain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 172 | |
| 2 | 2020 | 111 | |
| 3 | 2021 | 45 | |
| 4 | 2021 | 4 | |
| 5 | 2024 | 1 |
About Ashwin Narain
Ashwin Narain is a scholar working on Molecular Biology, Oncology, Biomaterials, Hematology and Biomedical Engineering, having authored 5 papers that have together received 333 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), RNA Research and Splicing (2 papers), RNA and protein synthesis mechanisms (2 papers), Ubiquitin and proteasome pathways (2 papers), Genomics and Chromatin Dynamics (2 papers), CAR-T cell therapy research (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Biomaterials (79 citations), Molecular Biology (223 citations), Biomedical Engineering (103 citations), Oncology (55 citations) and Pharmaceutical Science (12 citations). Ashwin Narain has collaborated with scholars based in Germany, India and United Kingdom. Frequent co-authors include Simran Asawa, Yogita Patil‐Sen, Bikash Adhikari, Elmar Wolf, Pranjali Bhandare, Andreas Schlösser, Apoorva Baluapuri, Christoph Sotriffer, Stephanie Heinzlmeir and Markus Vogt. Their work appears in journals such as Molecular Cell, Nature Chemical Biology, Nucleic Acids Research, Nanomedicine and STAR Protocols.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.